China eases IPO rules for firms developing reusable rockets
New guidelines exempt firms from some financial requirements Companies will need to meet reusable rocket tech milestones Beijing…
Hedge funds short healthcare providers as subsidies debate intensifies
LONDON, Dec 22 (Reuters) – Hedge funds last week sold more U.S. healthcare stocks than they bought for…
Japan to tighten regulations on mega-solar projects to protect nature, landscape
Regulations aim to protect environment and ensure safety Support for large-scale solar projects to end in FY2027 Perovskite…
Italy watchdog orders Meta to halt WhatsApp terms barring rival AI chatbots
MILAN, Dec 24 (Reuters) – Italy’s antitrust authority (AGCM) on Wednesday ordered Meta Platforms (META.O), opens new tab…
Canada unveils new rules to lower oil and gas methane emissions
New rules aim for 75% methane reduction by 2035 Previous draft rules criticized as too difficult by industry…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA approves first at-home device for depression
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
US FDA qualifies first AI tool to help speed liver disease drug development
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…
Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change
CHICAGO, Dec 2 (Reuters) – An independent review released on Tuesday by vaccine experts of more than 400…
Italy broadens antitrust probe into Meta over AI tools in WhatsApp
MILAN, Nov 25 (Reuters) – Italy’s antitrust authority said on Wednesday it had broadened the scope of its…
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…
US slashes 36% off Medicare spending on 15 high-priced medicines
Medicare says negotiated prices for 15 drugs to cut spending by 36% New prices to take effect in…